Mayo patient with life-threatening multidrug-resistant infection . . . Mark was Mayo Clinic's fourth patient to receive the investigational phage therapy treatment under a compassionate use basis He has since formed a special bond with Mayo's first phage therapy patient, who also was facing a potential amputation from a knee-joint replacement infection
Phage therapy shows potential for treating prosthetic joint infections ROCHESTER, Minn — Bacteriophages, or phages, may play a significant role in treating complex bacterial infections in prosthetic joints, according to new Mayo Clinic research The findings suggest phage therapy could provide a potential treatment for managing such infections, including those involving antibiotic-resistant microbes The research is published in the July issue of Clinical
Mayo Clinic patients find hope in individualized medicine in 2023 In a first, Mayo Clinic treats cardiology patient with phage therapy Mark Ulland, a Mayo Clinic patient, recently received a lifesaving combination of phage therapy followed by a heart transplant It is the first time Mayo Clinic has ever used phages to treat a cardiology patient
7 ways Mayo Clinic is leading to cure, connect and transform health . . . Mayo is also supporting a new phage therapy program to offer a potential life-saving alternative to antibiotics Phages are naturally occurring viruses that target and kill specific bacterial cells, including those that have grown resistant to multiple antibiotics
Celebrating Mayo Clinic women in medicine on International Women’s Day Dr Suh has a special interest in bacteriophages as a novel therapeutic for the treatment of infections, particularly multi-drug resistant and biofilm-mediated infections She treated Mayo Clinic’s first phage therapy patient and is heading efforts to create the Mayo Clinic Phage Therapy Program and run clinical trials
Scientists discover autoimmune disease associated with testicular . . . The enhanced phage technology identified autoantibodies targeting Kelch-like protein 11 (KLHL11), which is found in the testes and parts of the brain These results were correlated and validated with additional patient samples from the Mayo Clinic
Human Genome Project — ‘A race to the starting line’ Furthermore, the Center is focusing on phage therapy, the use of natural viruses and genetics to treat complex bacterial infections This will become increasingly important as antibiotic resistant infections increase across the globe